Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC29A1 | Q99808 | 4/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | SCN1A | P35498 | 2/20 | 0.55 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.55 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.51 |
| ▸ | THPO | P40225 | 2/20 | 0.51 |
| ▸ | MTOR | P42345 | 2/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25128874 | 0.91 | TPMT (0.58) | SLC29A1KMT2AKDM4EALDH1A1GAA | |
| SCHEMBL11848930 | 0.89 | SLC29A1 (0.55) | SLC29A1KMT2AKDM4EALDH1A1GAA | |
| SCHEMBL2612552 | 0.84 | SLC29A1 (0.54) | SLC29A1KMT2ASCN1ASCN2ASCN3A | |
| SCHEMBL28969683 | 0.84 | SLC29A1 (0.54) | SLC29A1KMT2AKDM4EALDH1A1PKM | |
| SCHEMBL2612567 | 0.84 | PTPN1 (0.68) | SLC29A1KMT2ASCN1ASCN2ASCN3A | |
| SCHEMBL9681889 | 0.84 | KMT2A (0.78) | SLC29A1KMT2AKDM4EALDH1A1GAA | |
| SCHEMBL13183860 | 0.83 | TSHR (0.54) | SLC29A1KMT2AKDM4EPKMSCN1A | |
| SCHEMBL6580266 | 0.82 | ALDH1A1 (0.59) | KMT2AKDM4EALDH1A1GAAPKM | |
| Ethyltrimethoxy Benzoate SCHEMBL4410910 | 0.81 | KMT2A (0.66) | SLC29A1KMT2AKDM4EALDH1A1PKM | |
| SCHEMBL25128844 | 0.80 | PTPN1 (0.45) | SLC29A1KMT2AKDM4EALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103819586-B | A kind of catalyst system for olefinic polyreaction | SINOPEC CORP. (CN) | 2016-03-30 | — | — | CN | disclosed |
| CN-103304691-B | A kind of catalyst system for olefinic polyreaction | SINOPEC CORP. (CN) | 2015-09-16 | — | — | CN | disclosed |
| CN-103819586-A | Catalyst system for alkene polymerization reaction | CHINA PETROLEUM & CHEMICAL | 2014-05-28 | — | — | CN | disclosed |
| CN-103304691-A | Catalyst system used for alkene polymerization | CHINA PETROLEUM & CHEMICAL | 2013-09-18 | — | — | CN | disclosed |
| US-20120231010-A1 | VINPOCETINE AND EBURN AMONINE DERIVATIVES FOR PROMOTING BONE GROWTH | OSTEOGENEX INC. (US) | 2012-09-13 | — | — | US | disclosed |
| US-20120231010-A1 | VINPOCETINE AND EBURN AMONINE DERIVATIVES FOR PROMOTING BONE GROWTH | OSTEOGENEX INC. (US) | 2012-09-13 | — | — | US | disclosed |
| US-8198292-B2 | Vinpocetine and eburnamonine derivatives for promoting bone growth, treating renal damage and cancer, and devices thereof | OSTEOGENEX, INC. (US) | 2012-06-12 | — | — | US | disclosed |
| US-20100003324-A1 | VINPOCETINE AND EBURN AMONINE DERIVATIVES FOR PROMOTING BONE GROWTH | OSTEOGENEX INC. (US) | 2010-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120231010-A1 | VINPOCETINE AND EBURN AMONINE DERIVATIVES FOR PROMOTING BONE GROWTH | BMP6, ATP6V1B1, WNT1 | SLC29A1 462/4885KMT2A 1675/4885KDM4E 1359/4885 |
| US-20100003324-A1 | VINPOCETINE AND EBURN AMONINE DERIVATIVES FOR PROMOTING BONE GROWTH | BMP6, ATP6V1B1, WNT1 | SLC29A1 462/4885KMT2A 1675/4885KDM4E 1359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.